NCT04854044View on ClinicalTrials.gov

ONC201 and Radiation Therapy Before Surgery for the Treatment of Recurrent Glioblastoma

PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

May 1, 2021

Primary Completion Date

July 1, 2025

Study Completion Date

July 1, 2026

Conditions
Recurrent GlioblastomaRecurrent GliosarcomaRecurrent Supratentorial GlioblastomaSupratentorial Gliosarcoma
Interventions
DRUG

Akt/ERK Inhibitor ONC201

Given orally

RADIATION

Radiation Therapy

Undergo radiation therapy

PROCEDURE

Resection

Undergo surgical resection

Trial Locations (1)

90095

UCLA / Jonsson Comprehensive Cancer Center, Los Angeles

Sponsors

Collaborators (1)

Oncoceutics, Inc.
All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

collaborator

Oncoceutics, Inc.

INDUSTRY

collaborator

University of California, Los Angeles

OTHER

lead

Jonsson Comprehensive Cancer Center

OTHER